|
1
|
Kang S, Kim Y, Kim S, Ko JY, Kim JH. Short and scalable synthesis of cynandione A. Org Biomol Chem 2023; 21:1868-1871. [PMID: 36762547 DOI: 10.1039/d2ob02317b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Abstract
A two-step gram-scale synthesis of cynandione A is described. The key to success is the one-pot tandem oxidation/regioselective arylation of 1,4-hydroquinone in the presence of an excess amount of oxidant. Natural bond orbital charge analysis was performed in order to understand the regioselectivity of the arylation step. The highly practical and scalable synthesis developed herein is expected to assist the in-depth biological evaluation of cynandione A in various animal models.
Collapse
Affiliation(s)
- Seoungwoo Kang
- College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
| | - Yeonjoon Kim
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, USA
| | - Seonah Kim
- Chemistry Department, Colorado State University, Fort Collins, Colorado 80523, USA
| | - Ju Young Ko
- College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
| | - Jae Hyun Kim
- College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
| |
Collapse
|
|
2
|
Wang L, Cai F, Zhao W, Tian J, Kong D, Sun X, Liu Q, Chen Y, An Y, Wang F, Liu X, Wu Y, Zhou H. Cynanchum auriculatum Royle ex Wight., Cynanchum bungei Decne. and Cynanchum wilfordii (Maxim.) Hemsl.: Current Research and Prospects. Molecules 2021; 26:7065. [PMID: 34885647 PMCID: PMC8658831 DOI: 10.3390/molecules26237065] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2021] [Revised: 11/13/2021] [Accepted: 11/17/2021] [Indexed: 01/12/2023] Open
Abstract
Cynanchum auriculatum Royle ex Wight. (CA), Cynanchum bungei Decne. (CB) and Cynanchum wilfordii (Maxim.) Hemsl. (CW) are three close species belonging to the Asclepiadaceous family, and their dry roots as the bioactive part have been revealed to exhibit anti-tumor, neuroprotection, organ protection, reducing liver lipid and blood lipid, immunomodulatory, anti-inflammatory, and other activities. Until 2021, phytochemistry investigations have uncovered 232 compounds isolated from three species, which could be classified into C21-steroids, acetophenones, terpenoids, and alkaloids. In this review, the morphology characteristics, species identification, and the relationship of botany, extraction, and the separation of chemical constituents, along with the molecular mechanism and pharmacokinetics of bioactive constituents of three species, are summarized for the first time, and their phytochemistry, pharmacology, and clinical safety are also updated. Moreover, the direction and limitation of current research on three species is also discussed.
Collapse
Affiliation(s)
- Lu Wang
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Fujie Cai
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Wei Zhao
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Jinli Tian
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Degang Kong
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Xiaohui Sun
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Qing Liu
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Yueru Chen
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Ying An
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Fulin Wang
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Xue Liu
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| | - Yi Wu
- Institute of Traditional Chinese Veterinary Medicine, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China;
| | - Honglei Zhou
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; (L.W.); (F.C.); (W.Z.); (J.T.); (D.K.); (X.S.); (Q.L.); (Y.C.); (Y.A.); (F.W.); (X.L.)
| |
Collapse
|
|
3
|
Sawamoto A, Kanazaki A, Nakanishi M, Amakura Y, Yoshimura M, Uchiyama N, Hakamatsuka T, Okuyama S, Nakajima M. Cynandione A causes a dynamic change in SIRT1 nuclear trafficking via PKA signaling and beige adipocyte differentiation in 3T3-L1 cells. Eur J Pharmacol 2021; 909:174382. [PMID: 34329615 DOI: 10.1016/j.ejphar.2021.174382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Revised: 07/13/2021] [Accepted: 07/22/2021] [Indexed: 11/29/2022]
Abstract
Inducible brown-like adipocytes, also known as beige adipocytes, dissipate energy through thermogenesis. Although recent reports suggest that silent information regulator 2 homolog 1 (SIRT1) promotes beige adipocyte differentiation (beiging), the activation mechanism of SIRT1 remains unknown. Here, we report that cynandione A (CA), a major component of Cynanchum wilfordii, causes dynamic changes in SIRT1 nuclear trafficking via protein kinase cAMP-dependent (PKA) signaling and induces the beiging process in adipocyte lineage cells. SIRT1 is located in both the cytoplasm and the nucleus of 3T3-L1 cells. Using cell fractionation and RNA interference experiments, we found that the translocation of SIRT1 from the cytoplasm to the nucleus was enhanced after CA treatment and was followed by upregulation of beige adipocyte-related gene expression. Moreover, we found that CA-induced SIRT1 nuclear trafficking is dependent on the PKA signaling pathway. These results suggest a novel mechanism of CA by which PKA signaling promotes SIRT1 nuclear trafficking, which permits the docking of SIRT1 to its nuclear substrates, leading to beiging in 3T3-L1 cells.
Collapse
Affiliation(s)
- Atsushi Sawamoto
- Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan
| | - Asami Kanazaki
- Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan
| | - Masayuki Nakanishi
- Department of Biochemistry, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan
| | - Yoshiaki Amakura
- Department of Pharmacognosy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan
| | - Morio Yoshimura
- Department of Pharmacognosy, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan
| | - Nahoko Uchiyama
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan
| | - Takashi Hakamatsuka
- National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan
| | - Satoshi Okuyama
- Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan
| | - Mitsunari Nakajima
- Department of Pharmaceutical Pharmacology, College of Pharmaceutical Sciences, Matsuyama University, 4-2 Bunkyo-cho, Matsuyama, Ehime, 790-8578, Japan.
| |
Collapse
|
|
4
|
Shin SM, Cho YM, Kwon JE, Lee SR, Kang SC. Supplementation with Cynanchum wilfordii radix extract for 8 weeks lowers serum total cholesterol: A controlled, randomized, double-blind clinical trial. Phytother Res 2020; 34:2313-2322. [PMID: 32243009 DOI: 10.1002/ptr.6682] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 02/26/2020] [Accepted: 03/12/2020] [Indexed: 12/20/2022]
Abstract
This trial aimed to determine the effect of a standardized Cynanchum wilfordii Radix extract (CWE) on the lipid profiles of individuals with elevated total cholesterol (T-Chol) using a double-blind randomized placebo-controlled design. Ninety-six Korean individuals with elevated T-Chol level (200-240 mg/dL) were recruited and randomly allocated to groups that received VasH300 (300 mg CWE/day, n = 32), VasH600 (600 mg CWE/day, n = 32), or a placebo (n = 32) groups. Primary outcomes included T-Chol, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, triglyceride, and safety (adverse events, biochemical parameters, and hematological parameters). Data were compared using a one-way analysis of variance followed by Duncan's post-hoc tests (among groups) and paired t tests (within groups). Values for T-Chol and LDL-cholesterol were significantly reduced in the VasH300 and groups (VasH300: 4.0 and 6.4%, respectively; VasH600; 3.8 and 5.8% respectively; both p < .05) compared with the placebo group and were not dose-dependent. VasH300 significantly improved the lipid profiles of individuals with elevated T-Chol without any serious side effects. Daily supplementation with VasH might be an alternative strategy with which to modify cholesterol-related parameters, especially in individuals with elevated T-Chol levels.
Collapse
Affiliation(s)
- Seon Mi Shin
- Department of Korean Internal Medicine, College of Korean Medicinem, Semyung University, Jecheon, Republic of Korea
| | - Young Mi Cho
- Department of Clinical Research, Research Mentor Co. Ltd., Seoul, Republic of Korea
| | - Jeong Eun Kwon
- Department of Oriental Medicine Biotechnology, College of Life Sciences, Kyung Hee University, Yongin, Republic of Korea
| | - Sung Ryul Lee
- Department of Convergence Biomedical Science, Cardiovascular and Metabolic Disease Cencer, College of Medicine, Inje University, Busan, Republic of Korea
| | - Se Chan Kang
- Department of Oriental Medicine Biotechnology, College of Life Sciences, Kyung Hee University, Yongin, Republic of Korea
| |
Collapse
|
|
5
|
Chen WH, Zhang ZZ, Ban YF, Rahman K, Ye BZ, Sun XL, Tan HY, Zheng XH, Liu HY, Xu LC, Yan B, Han T. Cynanchum bungei Decne and its two related species for "Baishouwu": A review on traditional uses, phytochemistry, and pharmacological activities. JOURNAL OF ETHNOPHARMACOLOGY 2019; 243:112110. [PMID: 31351190 DOI: 10.1016/j.jep.2019.112110] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Revised: 07/22/2019] [Accepted: 07/23/2019] [Indexed: 06/10/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Cynanchum bungei Decne. (CB) (Asclepiadaceae) and its two related species Cynanchum auriculatum Royle ex Wight. (CA) and Cynanchum wilfordii (Maxim.) Hemsl. (CW) are well known Chinese herbal medicines known by the name Baishouwu. Among them, CB has long been used for nourishing the kidney and liver, strengthening the bones and muscles, and regulating stomachache. However, to date, no comprehensive review on Baishouwu has been published. AIM OF THE REVIEW This review aims to provide a comprehensive summary on traditional uses, phytochemistry, pharmacology, and toxicology of the three herbal components of Baishouwu with the ultimate objective of providing a guide for future scientific and therapeutic potential use of Baishouwu. MATERIAL AND METHODS A literature search was undertaken on CB, CA and CW by analyzing the information from scientific databases (SciFinder, Pubmed, Elsevier, Google Scholar, Web of Science, and Baidu Scholar). Information was also gathered from local classic herbal literatures and conference papers on ethnopharmacology and the information provided in this review has been obtained from peer-reviewed papers. RESULTS Comparative analysis of literature search indicate that ethnopharmacological use of CB was recorded in China, however, CA and CW have been used in China, Korea and Japan. To date, 151 chemical compounds have been isolated from these species, and the major chemical constituents have been revealed to be acetophenones, C21-steroids, terpenoids, and alkaloids. These compounds and extracts have been proven to exhibit significant pharmacological activities, including anti-tumor, anti-inflammatory, immunomodulatory, hypolipidemic, anti-obesity, hepatoprotective, antifungal, antiviral, anti-depressant, vasodilating and estrogenic activities. CONCLUSIONS CB, CA and CW collectively known as Baishouwu are valuable medicinal herbs with multiple pharmacological activities. The traditional use for nourishing liver is closely associated with the hepatoprotective activity. The available literature performs that various of the activity of Baishouwu can be attributed to acetophenones and C21-steroids. It is high time that more efforts should be focused on the underlying mechanisms of their beneficial bioactivities and the structure activity relationship of the constituents, as well as their potential synergistic and antagonistic effects. The proper toxicology evaluation is crucial to guarantee the safety, efficacy, and eligibility for medical use. Further research on the comprehensive evaluation of medicinal quality and the understanding of multi-target network pharmacology of Baishouwu is in great request.
Collapse
Affiliation(s)
- Wen-Hua Chen
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Jinan, 250355, China
| | - Zhen-Zhen Zhang
- Naval Medical Institute of PLA, 880 Xiangyin Road, Shanghai, 200433, China
| | - Yan-Fei Ban
- Department of Pharmacognosy, School of Pharmacy, Navy Medical University, 325 Guohe Road, Shanghai, 200433, China
| | - Khalid Rahman
- Faculty of Science, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool, L3 3AF, UK
| | - Bing-Zhu Ye
- Department of Pharmacognosy, School of Pharmacy, Navy Medical University, 325 Guohe Road, Shanghai, 200433, China
| | - Xiao-Lei Sun
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Jinan, 250355, China; Department of Pharmacognosy, School of Pharmacy, Navy Medical University, 325 Guohe Road, Shanghai, 200433, China
| | - Hui-Ying Tan
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Jinan, 250355, China
| | - Xiao-Hua Zheng
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Jinan, 250355, China
| | - Hong-Yan Liu
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Jinan, 250355, China
| | - Ling-Chuan Xu
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Jinan, 250355, China.
| | - Bin Yan
- School of Pharmacy, Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Jinan, 250355, China.
| | - Ting Han
- Department of Pharmacognosy, School of Pharmacy, Navy Medical University, 325 Guohe Road, Shanghai, 200433, China.
| |
Collapse
|
|
6
|
Youn JS, Ham YM, Yoon WJ, Choi HC, Lee JE, Cho B, Kim JY. Cynanchum wilfordii Etanolic Extract Controls Blood Cholesterol: A Double-blind, Randomized, Placebo-Controlled, Parallel Trial. Nutrients 2019; 11:E836. [PMID: 31013851 PMCID: PMC6521060 DOI: 10.3390/nu11040836] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2019] [Revised: 04/06/2019] [Accepted: 04/10/2019] [Indexed: 12/26/2022] Open
Abstract
We evaluated the effects of Cynanchum wilfordii (CW) ethanolic extract on blood cholesterol levels in adults with high low-density lipoprotein cholesterol (LDL-C) levels. In a double-blind, randomized, placebo-controlled, parallel trial, 84 subjects were recruited. Participants were randomly divided into two groups with a low-dose (300 mg/d) or high-dose (600 mg/d) of CW. Levels of very low-density lipoprotein (p = 0.022) and triglycerides (p = 0.022) were significantly lower in the low-dose CW group than in the placebo group after 8 weeks. In a subgroup of participants with LDL-C≥ 150 mg/dL (n = 33), there was a significant decrease in total cholesterol (low-dose, p = 0.012; high-dose, p = 0.021), apolipoprotein B (low-dose, p = 0.022; high-dose, p = 0.016), and cholesteryl ester transfer protein (low-dose, p = 0.037; high-dose, p = 0.016) after 8 weeks of CW. The correlation between changes in total cholesterol and baseline LDL-C levels was significant in the groups that received both doses of CW (low-dose, p = 0.010; high-dose, p = 0.015). These results show that the CW ethanolic extract can regulate blood cholesterol in subjects with LDL-C≥ 150 mg/dL.
Collapse
Affiliation(s)
- Ji Sun Youn
- Department of Food Science and Technology, Seoul National University of Science and Technology, Seoul 01811, Korea.
| | - Young Min Ham
- Biodiversity Research Institute, Jeju Technopark, Seogwipo, Jeju 63608, Korea.
| | - Weon-Jong Yoon
- Biodiversity Research Institute, Jeju Technopark, Seogwipo, Jeju 63608, Korea.
| | - Ho-Chun Choi
- Healthcare system Gangnam Center, Seoul National University Hospital, Seoul 06236, Korea.
| | - Ji Eun Lee
- Department of Family Medicine, CHA Bundang Medical Center, Seongnam-si 13496, Korea.
| | - Belong Cho
- Department of Family Medicine, Seoul National University Hospital, Seoul 03080, Korea.
| | - Ji Yeon Kim
- Department of Food Science and Technology, Seoul National University of Science and Technology, Seoul 01811, Korea.
| |
Collapse
|